News und Analysen
3 Dividend Stocks to Buy and Hold for the Next Decade
What should investors do when stocks are tanking over the short term? Probably the best answer is to think long term.
Three Motley Fool contributors think they've found great dividend stocks to own
2 Dividend Stocks to Buy Hand Over Fist in April
One factor that keeps some investors away from healthcare stocks is the sector's dearth of generous and reliable dividend payers. This stands to reason, as nearly every stage of drug development and
3 Growth Stocks That Have Turned $1,000 Into More Than $100,000 in 20 Years
Three stocks which have generated 100-bagger returns for investors over the past 20 years are Booking Holdings (NASDAQ: BKNG), Apple (NASDAQ: AAPL), and Regeneron Pharmaceuticals (NASDAQ: REGN)
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday
As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the stock market on Thursday. It had one of its worst
3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months
Is the excitement surrounding chipmaker Nvidia fading? As of Monday, shares of the tech giant were down 19% since the start of 2025. Whether that's due to its high valuation, concerns about the
This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years
There are many dividend stocks on equity markets, but not all are attractive to income investors. Those that go beyond paying a quarterly payout but also consistently raise their dividends -- all
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna
In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). These two vaccine makers
The Smartest Biotech Stocks to Buy With $50
One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that perform well tend to attract plenty of attention that bids up their share
Is Pfizer Stock a Buy?
Pfizer's (NYSE: PFE) share price has fallen more than the S&P 500 so far this year. The big pharma stock is nearly 60% below its high set in late 2022. By most standards, Pfizer looks like the
Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now
As of Monday, the Nasdaq Composite index had tumbled more than 11% since the start of the year. The outlook for the economy is worrisome, as trade wars and promised tariffs could lead to disaster
2 Absurdly Cheap Stocks to Buy and Hold for Years
Buying stock in great companies when they are dealing with some short-term issue that creates stock price weakness can set investors up for big gains down the road. As long as the business is still
2 Beaten-Down Stocks to Buy and Hold for a Decade
Recent market volatility notwithstanding, equities generally deliver solid returns over long periods, like a decade. The key is to purchase shares of robust companies, occasionally adding more, and
Good News for AMD Stock Investors
In this video, I will talk about recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?
Viking Therapeutics (NASDAQ: VKTX) is operating in one of the highest-growth pharma areas around. I'm talking about the weight loss drug market -- one that Morgan Stanley analysts say may multiply
Is AT&T Stock a Buy?
AT&T (NYSE: T) is often considered a slow-growth stock -- the kind of investment people hold for stable returns and dividends rather than market-beating gains. But over the past 12 months, the
Why Major Pharmaceutical Stocks Tumbled on Tuesday
Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump administration's promised tariffs were set to go into effect the following
Why Shares of Axsome Therapeutics Slumped Today
Shares of biopharmaceutical company Axsome Therapeutics (NASDAQ: AXSM) had declined 6% at 11 a.m. ET today. The slump comes after the company announced the results of a phase 3 trial of solriamfetol
EQS-News: Newron presents 2024 financial results and provides 2025 outlook
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4%, 5.6%, and
Where Will AT&T Stock Be in 1 Year?
AT&T (NYSE: T) shareholders have plenty to celebrate, with the stock up 24% thus far in 2025. The telecommunications giant has presented robust earnings, reinforcing an optimistic long-term outlook
VALBIOTIS SA: Valbiotis® strengthens its foothold in pharmacies with two strategic partnerships
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
Building a retirement portfolio of $1 million or more is within reach for many Americans. The primary things you'll need are time and money to invest.
Do you want $1 million in retirement? There's
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer
EQS-News: Biotest AG increases sales by 6% in financial year 2024
Here's How Many Shares of AT&T You Should Own to Get $1,000 in Yearly Dividends
Dividend-paying stocks are hard to beat for income. If you're retired, you can use that money for your living expenses, and if you're still far from retirement, you might simply reinvest those





